Navigation Links
A Biologic Drug Superior to Spiriva in Reducing COPD-Related Exacerbations Would Earn a Higher Patient Share in Europe Than in the U.S.
Date:1/12/2009

Spiriva Will Remain the Gold Standard Treatment Through 2017, According to a New Report from Decision Resources.

WALTHAM, Mass., Jan. 12 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a biologic drug that is superior to Boehringer Ingelheim/Pfizer's Spiriva in reducing yearly COPD-related exacerbations would earn a higher patient share in Europe (30 percent) than in the U.S. (15 percent) according to surveyed European and U.S. pulmonologists. COPD-related exacerbations are episodic events often requiring hospitalization.

"A biological drug that provides fewer yearly COPD-related exacerbations compared to current therapies holds much commercial promise," said Regina Jammen, M.S., analyst at Decision Resources. "Enthusiasm from U.S. and European pulmonologists for a biologic drug with the potential to dramatically reduce yearly exacerbation rates likely reflects physicians' recognition of not only the long-term therapeutic benefits of such a drug, but also its economic benefits."

The new report entitled Chronic Obstructive Pulmonary Disease: Blockbuster Potential Exists for Biologic Drugs That Dramatically Reduce Exacerbation Rates finds that Spiriva will remain Decision Resources' clinical gold standard treatment for COPD over the next eight years even though emerging drugs such as Forest/Almirall's aclidinium, Novartis's indacaterol, Boehringer Ingelheim's BI-1744/tiotropium and Nycomed/Mitsubishi Tanabe's roflumilast will offer therapeutic benefits to COPD patients.

About the Report

Chronic Obstructive Pulmonary Disease: Blockbuster Potential Exists for Biologic Drugs That Dramatically Reduce Exacerbation Rates is a DecisionBase 2009 report. DecisionBase 2009 is a decision-support tool that provides in-depth analysis of unmet need,
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Biologic treatment for rheumatoid arthritis and the risk of cancer
2. Thomson Scientific Announces BONDplus for Biological Researchers
3. Neurobiological Technologies Reports Going Concern Qualification
4. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
5. Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis
6. Study questions assumptions about human sensitivity to biological motion
7. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
8. Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
9. Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
10. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
11. CalbaTech Reports That LifeStems Biologics License Has Been Renewed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... According to a recent report by iData ... into the surgical robotics market may find ... MIS field dominated by Intuitive. These companies are expected ... market by 2020. , “The MIS robotic device ... and President of iData. “System sales for the da ...
(Date:11/27/2014)... Acapulco, Guerrero (PRWEB) November 27, 2014 ... the time individuals allot to sleep has lessened, ... televisions and laptops, the quality of sleep has ... workers falls asleep on the job (Reference: ... American worker’s productivity index by an incalculable amount, ...
(Date:11/27/2014)... 2014 "As a nurse I see ... of urinary incontinence," said an inventor from Whiting, N.J. ... specialized accessory to prevent leakage and keep them dry ... urine leakage. This prevents stains on pants, skirts and ... pad ensures that the individual has time to get ...
(Date:11/27/2014)... 26, 2014 (HealthDay News) -- Most babies and young ... the U.S. Food and Drug Administration says. Over-the-counter ... to children younger than 2 because they could cause ... American adults average about three colds a year, ... a cold, parents might want to give them pain ...
(Date:11/27/2014)... November 27, 2014 In order to enable ... Sharpes, Fla., designed an easy way to avoid touching a ... He then created a prototype of the patent-pending Toilet Tamer, ... a toilet seat and/or lid in a more sanitary manner. ... spread of germs. Overall, it promotes good hygiene and peace ...
Breaking Medicine News(10 mins):Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2
... ... DesignState capablities as well as offering productized services for PLM. To support new initiatives ... Richard Haner, formerly a partner at Centerpoint Ventures, as Company Chairman. , ... (PRWEB) April 14, 2010 -- Zero Wait-State ...
... ... most credible members this Friday, to speak out about the realities and horrors of body ... no recourse for their suffering. , ... (PRWEB) -- On Friday, April 16, Freedom From Covert Harassment and Surveillance ...
... ... Certified Physicians and IT experts of Mobile Medical Applications, LLC. The app provides an ... ... 2010 -- According to the Alzheimer’s Association, Alzheimer,s disease affects approximately 5 million people ...
... University has been awarded $5.8 million in American Recovery ... adoption and meaningful use of health information technology (HIT) ... field. The funding is provided in ... the education of about 150 additional students over three ...
... In animal studies, they drew more stem cells to damaged ... report they,ve used magnets to guide stem cells to damaged ... it more likely that the heart will retain the cells, ... "Stem cell therapies show great promise as a treatment for ...
... risk, Singapore researchers say , TUESDAY, April 13 (HealthDay News) ... military and young adults showed higher rates of infection with ... 30 percent of military personnel, who tend to be younger, ... general population, 6.5 percent of hospital employees and 1.2 percent ...
Cached Medicine News:Health News:Zero Wait-State Announces New Leadership Team and Strategic Focus 2Health News:Zero Wait-State Announces New Leadership Team and Strategic Focus 3Health News:Professional Members of Human Rights Organization Hold Press Conference to Highlight Government Invasion of Privacy 2Health News:Professional Members of Human Rights Organization Hold Press Conference to Highlight Government Invasion of Privacy 3Health News:World's First Mobile Application for Alzheimer's Disease Risk Assessment 2Health News:World's First Mobile Application for Alzheimer's Disease Risk Assessment 3Health News:OHSU awarded $5.8 million to expand health information technology education 2Health News:OHSU awarded $5.8 million to expand health information technology education 3Health News:Magnets Might Boost Stem Cell Therapy 2Health News:Study Finds Military Prone to Infection With H1N1 Flu 2Health News:Study Finds Military Prone to Infection With H1N1 Flu 3
(Date:11/26/2014)... , Nov. 26, 2014  CARsgen, a leader in ... immunotherapy to treat a variety of cancers, today announced ... BVCF, a China -based healthcare private ... company focused on the development of new therapeutics for ... Shanghai Cancer Institute and Shanghai Renji Hospital, the company ...
(Date:11/26/2014)... , Nov. 26, 2014 The medical ... a rate of 4%, with world market revenues ... Information. MRI and other types of medical imaging ... treatment of numerous medical conditions in children and ... techniques. Kalorama,s report, Medical Imaging Markets , ...
(Date:11/26/2014)... DALLAS , November 25, 2014 ... Surgical Instruments Market by Power Source (Electric, Battery, ... Console, Cables, Blade, Burr, Cart), by Application (Orthopedic, ... 2019" published by MarketsandMarkets, the global Powered Surgical Instruments ... to $1.6 Billion in 2014 and is expected ...
Breaking Medicine Technology:CARsgen Completes Series A Financing 2Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4
... ESRX ), one of the largest pharmacy benefit ... release its third quarter earnings on Tuesday, October 25, 2011 ... call to discuss third quarter results on Wednesday, October 26, ... This call is being webcast and can be ...
... YORK, Oct. 17, 2011 Levi & Korsinsky is investigating ... the "Company") (NASDAQ: ANDS ) for possible breaches ... connection with the sale of the Company to Roche Holding ... receive $3.70 in cash per share of Anadys stock they ...
Cached Medicine Technology:The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Anadys Pharmaceuticals Inc. in Connection with the Sale of the Company to Roche Holding AG 2
Immuno-turbidimetric Assay for Protein S Antigen. Suspension of microlatex particles coated with specific antibodies....
... Colorimetric Assay ... (UH) and Low ... (LMWH).Chromogenic substrate CBS ... freeze-dried; purified bovine ...
Substrate Plasma for Factor II Assay by STA© Analyzers. Freeze-dried human serum and absorbed bovine plasma, the latter providing factor V and fibrinogen to the test system....
Substrate Plasma for Factor X Assay by STA© Analyzers. Freeze-dried human plasma from which factor X has been removed by selective immuno-adsorption....
Medicine Products: